In summary, we demonstrate that RKIP is critical for radioresponse of NPC cells both in vitro and in vivo, and its reduction correlates with NPC radioresistance and poor patient prognosis, and RKIP reduction promotes NPC radioresistance via increasing ERK and AKT activity. This evidence concerns the gene MAPK1 and nasopharyngeal carcinoma.